In Precision Cut CRC Tumor Slice Cultures, treatment with LY6G6D/CD3 induced activation of tumor infiltrating T cells, measured by released inflammatory cytokines and granzyme B, only in LY6G6D-positive tumors. This evidence concerns the gene GZMB and neoplasm.